CA Stock MarketDetailed Quotes

NOVA Nova Mentis Life Science Corp

Watchlist

0.005
0.0000.00%

15min DelayMarket Closed Nov 6 12:22 ET

741.59KMarket Cap-250P/E (TTM)

Nova Mentis Life Science Corp Key Stats

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(Q3)Sep 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

Assets

Current assets

Cash, cash equivalents and short term investments

--12.06K

-80.85%21.82K

-94.71%24.44K

-89.92%113.94K

21.85%266.52K

--266.52K

-40.44%461.95K

-43.70%634.36K

-25.23%1.13M

-89.78%218.73K

-Cash and cash equivalents

--12.06K

-80.85%21.82K

-94.71%24.44K

-89.92%113.94K

21.85%266.52K

--266.52K

-39.79%461.95K

-43.44%634.36K

-24.97%1.13M

-89.76%218.73K

Receivables

--4.06K

-18.18%7.47K

-40.92%7.13K

-90.57%9.13K

-88.96%7.75K

--7.75K

-75.97%12.07K

155.40%93.42K

251.56%96.85K

305.52%70.21K

-Accounts receivable

--4.06K

-18.18%7.47K

-40.92%7.13K

-90.57%9.13K

-88.96%7.75K

--7.75K

-75.97%12.07K

155.40%93.42K

251.56%96.85K

305.52%70.21K

Prepaid assets

--0

6.13%10.2K

353.65%92.61K

-78.91%8.19K

--8.19K

-98.08%9.61K

-98.47%11.65K

-97.31%20.41K

-90.71%38.83K

Total current assets

--16.12K

-86.42%29.29K

-91.36%41.77K

-82.71%215.68K

-13.82%282.46K

--282.46K

-63.66%483.63K

-61.66%739.42K

-45.87%1.25M

-87.30%327.77K

Non current assets

Net PPE

--10.23K

-20.49%10.81K

-20.65%12.12K

-20.85%13.59K

-20.93%14.32K

--14.32K

-21.14%15.27K

-21.32%16.22K

-24.23%17.17K

-21.62%18.12K

-Gross PPE

--56.05K

0.00%56.05K

--56.05K

0.00%56.05K

-Accumulated depreciation

---45.83K

-6.56%-45.25K

-7.73%-43.94K

-9.20%-42.46K

-10.00%-41.73K

---41.73K

-11.16%-40.78K

-12.40%-39.83K

-16.44%-38.89K

-15.17%-37.94K

Non current note receivables

----

--0

--660.63K

--607.95K

--570.46K

--535.27K

Total non current assets

--10.23K

-20.49%10.81K

-98.21%12.12K

-97.69%13.59K

-97.41%14.32K

--14.32K

-67.14%675.9K

-69.68%624.17K

-71.48%587.62K

18.92%553.39K

Total assets

--26.35K

-82.51%40.1K

-95.35%53.89K

-87.50%229.27K

-66.32%296.79K

--296.79K

-65.78%1.16M

-65.80%1.36M

-57.96%1.83M

-71.08%881.16K

Liabilities

Current liabilities

Current debt and capital lease obligation

--60K

----

-Current debt

--60K

----

Payables

----

--654.93K

--343.46K

-39.48%255.44K

--255.44K

----

--164.19K

----

10.21%422.06K

-accounts payable

----

--306.73K

--162.02K

-70.14%118.86K

--118.86K

----

--118.6K

----

25.35%398.13K

-Due to related parties current

----

--348.2K

--181.44K

470.76%136.58K

--136.58K

----

--45.59K

----

-63.39%23.93K

Current liabilities

--1.07M

189.73%995.08K

191.25%654.93K

19.18%343.46K

-39.48%255.44K

--255.44K

-65.75%224.87K

-44.32%164.19K

13.42%288.19K

10.21%422.06K

Non current liabilities

Total non current liabilities

--0

Total liabilities

--1.07M

189.73%995.08K

191.25%654.93K

19.18%343.46K

-39.48%255.44K

--255.44K

-65.75%224.87K

-44.32%164.19K

13.42%288.19K

10.21%422.06K

Shareholders'equity

Share capital

--50.26M

0.15%50.26M

0.84%50.19M

1.51%50.19M

3.51%50.07M

--50.07M

2.77%49.77M

3.05%49.77M

2.36%49.44M

0.27%48.37M

-common stock

--50.26M

0.15%50.26M

0.84%50.19M

1.51%50.19M

3.51%50.07M

--50.07M

2.77%49.77M

3.05%49.77M

2.36%49.44M

0.27%48.37M

Retained earnings

---59.52M

-1.43%-59.43M

-3.66%-59.08M

-4.21%-58.59M

-4.44%-58.06M

---58.06M

-6.79%-57M

-8.90%-56.59M

-9.08%-56.23M

-5.07%-55.6M

Gains losses not affecting retained earnings

--8.22M

-0.92%8.22M

1.57%8.29M

-0.48%8.29M

4.45%8.03M

--8.03M

6.32%8.16M

8.93%8.02M

13.24%8.33M

4.75%7.69M

Other equity interest

----

--8.4K

----

Total stockholders'equity

---1.05M

-736.34%-954.98K

-164.31%-601.04K

-107.38%-114.19K

-90.99%41.34K

--41.34K

-65.78%934.66K

-67.52%1.2M

-62.38%1.55M

-82.76%459.1K

Total equity

---1.05M

-736.34%-954.98K

-164.31%-601.04K

-107.38%-114.19K

-90.99%41.34K

--41.34K

-65.78%934.66K

-67.52%1.2M

-62.38%1.55M

-82.76%459.1K

Accounting Standards

US-GAAP

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(Q3)Sep 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021
Assets
Current assets
Cash, cash equivalents and short term investments	--12.06K	-80.85%21.82K	-94.71%24.44K	-89.92%113.94K	21.85%266.52K	--266.52K	-40.44%461.95K	-43.70%634.36K	-25.23%1.13M	-89.78%218.73K
-Cash and cash equivalents	--12.06K	-80.85%21.82K	-94.71%24.44K	-89.92%113.94K	21.85%266.52K	--266.52K	-39.79%461.95K	-43.44%634.36K	-24.97%1.13M	-89.76%218.73K
Receivables	--4.06K	-18.18%7.47K	-40.92%7.13K	-90.57%9.13K	-88.96%7.75K	--7.75K	-75.97%12.07K	155.40%93.42K	251.56%96.85K	305.52%70.21K
-Accounts receivable	--4.06K	-18.18%7.47K	-40.92%7.13K	-90.57%9.13K	-88.96%7.75K	--7.75K	-75.97%12.07K	155.40%93.42K	251.56%96.85K	305.52%70.21K
Prepaid assets	--0	--0	6.13%10.2K	353.65%92.61K	-78.91%8.19K	--8.19K	-98.08%9.61K	-98.47%11.65K	-97.31%20.41K	-90.71%38.83K
Total current assets	--16.12K	-86.42%29.29K	-91.36%41.77K	-82.71%215.68K	-13.82%282.46K	--282.46K	-63.66%483.63K	-61.66%739.42K	-45.87%1.25M	-87.30%327.77K
Non current assets
Net PPE	--10.23K	-20.49%10.81K	-20.65%12.12K	-20.85%13.59K	-20.93%14.32K	--14.32K	-21.14%15.27K	-21.32%16.22K	-24.23%17.17K	-21.62%18.12K
-Gross PPE	--56.05K	0.00%56.05K	0.00%56.05K	0.00%56.05K	0.00%56.05K	--56.05K	0.00%56.05K	0.00%56.05K	0.00%56.05K	0.00%56.05K
-Accumulated depreciation	---45.83K	-6.56%-45.25K	-7.73%-43.94K	-9.20%-42.46K	-10.00%-41.73K	---41.73K	-11.16%-40.78K	-12.40%-39.83K	-16.44%-38.89K	-15.17%-37.94K
Non current note receivables	----	----	----	----	--0	--0	--660.63K	--607.95K	--570.46K	--535.27K
Total non current assets	--10.23K	-20.49%10.81K	-98.21%12.12K	-97.69%13.59K	-97.41%14.32K	--14.32K	-67.14%675.9K	-69.68%624.17K	-71.48%587.62K	18.92%553.39K
Total assets	--26.35K	-82.51%40.1K	-95.35%53.89K	-87.50%229.27K	-66.32%296.79K	--296.79K	-65.78%1.16M	-65.80%1.36M	-57.96%1.83M	-71.08%881.16K
Liabilities
Current liabilities
Current debt and capital lease obligation	--60K	--60K	----	----	----	----	----	----	----	----
-Current debt	--60K	--60K	----	----	----	----	----	----	----	----
Payables	----	----	--654.93K	--343.46K	-39.48%255.44K	--255.44K	----	--164.19K	----	10.21%422.06K
-accounts payable	----	----	--306.73K	--162.02K	-70.14%118.86K	--118.86K	----	--118.6K	----	25.35%398.13K
-Due to related parties current	----	----	--348.2K	--181.44K	470.76%136.58K	--136.58K	----	--45.59K	----	-63.39%23.93K
Current liabilities	--1.07M	189.73%995.08K	191.25%654.93K	19.18%343.46K	-39.48%255.44K	--255.44K	-65.75%224.87K	-44.32%164.19K	13.42%288.19K	10.21%422.06K
Non current liabilities
Total non current liabilities	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Total liabilities	--1.07M	189.73%995.08K	191.25%654.93K	19.18%343.46K	-39.48%255.44K	--255.44K	-65.75%224.87K	-44.32%164.19K	13.42%288.19K	10.21%422.06K
Shareholders'equity
Share capital	--50.26M	0.15%50.26M	0.84%50.19M	1.51%50.19M	3.51%50.07M	--50.07M	2.77%49.77M	3.05%49.77M	2.36%49.44M	0.27%48.37M
-common stock	--50.26M	0.15%50.26M	0.84%50.19M	1.51%50.19M	3.51%50.07M	--50.07M	2.77%49.77M	3.05%49.77M	2.36%49.44M	0.27%48.37M
Retained earnings	---59.52M	-1.43%-59.43M	-3.66%-59.08M	-4.21%-58.59M	-4.44%-58.06M	---58.06M	-6.79%-57M	-8.90%-56.59M	-9.08%-56.23M	-5.07%-55.6M
Gains losses not affecting retained earnings	--8.22M	-0.92%8.22M	1.57%8.29M	-0.48%8.29M	4.45%8.03M	--8.03M	6.32%8.16M	8.93%8.02M	13.24%8.33M	4.75%7.69M
Other equity interest	----	----	----	----	--8.4K	--8.4K	----	----	----	----
Total stockholders'equity	---1.05M	-736.34%-954.98K	-164.31%-601.04K	-107.38%-114.19K	-90.99%41.34K	--41.34K	-65.78%934.66K	-67.52%1.2M	-62.38%1.55M	-82.76%459.1K
Total equity	---1.05M	-736.34%-954.98K	-164.31%-601.04K	-107.38%-114.19K	-90.99%41.34K	--41.34K	-65.78%934.66K	-67.52%1.2M	-62.38%1.55M	-82.76%459.1K
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List

Overall

No Data

NOVA Nova Mentis Life Science Corp

Nova Mentis Life Science Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow